Automated Decapping/Capping of Screw Cap Tubes
Micronic has announced the launch of an Automatic Screw Cap DeCapper system. The next-generation Screw Cap DeCapper is an innovative, easy-to-use device that provides automated decapping/capping of screw cap storage tubes in 96-tube racks in portrait or landscape formats. The device is able to cap or decap 96 Screw Cap tubes, in rows of 8 or 12, in just 60 seconds.
The new device is able to provide an automated capping/decapping solution for Micronic screw cap tubes, screw caps and the recently introduced low profile screw caps. Micronic low profile screw caps provide an unmatchable solution for biobanks and other laboratory facilities that need a space saving solution for their long-term sample storage at low temperatures.
The Automatic Screw Cap DeCapper includes new features such as real-time process monitoring, and torque monitoring for optimal tube sealing, to enhance sample security. An innovative “secure mode” further enhances sample security by decapping and recapping only one row at a time, minimising the time a tube is open and eliminating the risk of cross contamination. This feature also enables the rows to be paused for “point-of-use” pipetting between capping and recapping, which is very useful for manual workflows. A new turntable allows tube racks to be turned after decapping for better positioning in pipetting workflows. A laser sensor on the Automatic Screw Cap DeCapper detects the tube height so that no adapters are needed for different tube sizes. The devices graphical touchscreen interface simplifies programming and it clearly displays tubes to be capped or recapped which makes the Screw Cap DeCapper very easy to operate.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance